Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hegde

Showing results (471-480 of 657) with videos related to

Pageof 66
Sort By:
Molecular Cell|June 9, 2023
Mechanism of ribosome-associated mRNA degradation during tubulin autoregulationMarkus Höpfler, Eva Absmeier, Sew-Yeu Peak-Chew, et al.
Science (New York, N.Y.)|March 7, 2015
Protein targeting. Structure of the Get3 targeting factor in complex with its membrane protein cargoAgnieszka Mateja, Marcin Paduch, Hsin-Yang Chang, et al.
Indian Journal of Physiology and Pharmacology|May 4, 1999
A new physiological approach to control essential hypertensionW Selvamurthy, K Sridharan, U S Ray, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2006
Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureusNoe Reyes, Robert Skinner, Bret M Benton, et al.
Oncogene|April 27, 2010
The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cellsR N Pandey, R Rani, E-J Yeo, et al.
Plos One|February 3, 2021
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patientsNamrata S Patil, Wei Zou, Simonetta Mocci, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivoR M Eglen, C H Lee, W L Smith, et al.
Molecular Oncology|April 6, 2017
Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressorZahid Nawaz, Vikas Patil, Sivaarumugam Thinagararjan, et al.
Nature Structural & Molecular Biology|November 27, 2019
Mechanism of ribosome stalling during translation of a poly(A) tailViswanathan Chandrasekaran, Szymon Juszkiewicz, Junhong Choi, et al.
Journal of Clinical and Diagnostic Research : JCDR|January 7, 2014
Clinico-bacteriological study of chronic dacryocystitis cases in northern karnataka, IndiaPradeep A V, Satish S Patil, S V Koti, et al.
Pageof 66

Showing results (471-480 of 657) with videos related to

Sort By:
Pageof 66
Molecular Cell|June 9, 2023
Mechanism of ribosome-associated mRNA degradation during tubulin autoregulationMarkus Höpfler, Eva Absmeier, Sew-Yeu Peak-Chew, et al.
Science (New York, N.Y.)|March 7, 2015
Protein targeting. Structure of the Get3 targeting factor in complex with its membrane protein cargoAgnieszka Mateja, Marcin Paduch, Hsin-Yang Chang, et al.
Indian Journal of Physiology and Pharmacology|May 4, 1999
A new physiological approach to control essential hypertensionW Selvamurthy, K Sridharan, U S Ray, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2006
Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureusNoe Reyes, Robert Skinner, Bret M Benton, et al.
Oncogene|April 27, 2010
The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cellsR N Pandey, R Rani, E-J Yeo, et al.
Plos One|February 3, 2021
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patientsNamrata S Patil, Wei Zou, Simonetta Mocci, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivoR M Eglen, C H Lee, W L Smith, et al.
Molecular Oncology|April 6, 2017
Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressorZahid Nawaz, Vikas Patil, Sivaarumugam Thinagararjan, et al.
Nature Structural & Molecular Biology|November 27, 2019
Mechanism of ribosome stalling during translation of a poly(A) tailViswanathan Chandrasekaran, Szymon Juszkiewicz, Junhong Choi, et al.
Journal of Clinical and Diagnostic Research : JCDR|January 7, 2014
Clinico-bacteriological study of chronic dacryocystitis cases in northern karnataka, IndiaPradeep A V, Satish S Patil, S V Koti, et al.
Pageof 66